(Total Views: 640)
Posted On: 06/11/2020 3:26:50 PM
Post# of 72447
Similar logic was used when IPIX applied for grant from BARDA in Febuary, something along the line of the preliminary data must be great, otherwise Leo would not have applied.
http://www.ipharminc.com/press-release/2020/2...s-covid-19
Below is a list of companies and the amount awarded by BARDA to fight COVID-19.
https://www.medicalcountermeasures.gov/app/ba...VID19.aspx
Four months later, Leo has not updated shareholders on the status. Some said maybe the government has not heard of Brilacidin, to that I say the FDA granted QIDP designation to B in 2014.
Quote:
On a related note, the Company has submitted a preliminary summary of Brilacidin’s potential as a novel coronavirus treatment to the Biomedical Advanced Research and Development Authority (BARDA), which is dedicated to rapidly identifying and funding medical countermeasures to the COVID-19 outbreak.
http://www.ipharminc.com/press-release/2020/2...s-covid-19
Below is a list of companies and the amount awarded by BARDA to fight COVID-19.
https://www.medicalcountermeasures.gov/app/ba...VID19.aspx
Four months later, Leo has not updated shareholders on the status. Some said maybe the government has not heard of Brilacidin, to that I say the FDA granted QIDP designation to B in 2014.
(7)
(1)
